News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
139,328 Results
Type
Article (6352)
Company Profile (16)
Press Release (132959)
Multimedia
Podcasts (18)
Webinars (1)
Section
Business (50620)
Career Advice (174)
Deals (8281)
Drug Delivery (31)
Drug Development (18009)
Employer Resources (9)
FDA (3098)
Job Trends (3461)
News (72849)
Policy (5330)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (443)
Accelerated approval (19)
ADA (12)
Adcomms (1)
Allergies (60)
Alliances (5416)
ALS (57)
Alzheimer's disease (433)
Antibody-drug conjugate (ADC) (145)
Approvals (3412)
Artificial intelligence (99)
ASCO (79)
Autoimmune disease (108)
Automation (7)
Bankruptcy (64)
Belgium (4)
Best Places to Work (3019)
BIO (3)
Biologics (3)
BIOSECURE Act (2)
Biosimilars (70)
BioSpace Insights (13)
Biotechnology (11)
Bladder cancer (69)
Brain cancer (27)
Breast cancer (273)
Cancer (1928)
Cardiovascular disease (155)
Career advice (155)
Career pathing (6)
CAR-T (105)
CDC (6)
CDMO (29)
Celiac Disease (2)
Cell-line development (1)
Cell therapy (252)
Cervical cancer (16)
Clinical research (17288)
Collaboration (327)
Commercialization (5)
Compensation (227)
Complete response letters (16)
COVID-19 (585)
CRISPR (25)
C-suite (151)
Cystic fibrosis (36)
Data (3059)
Decentralized trials (1)
Denatured (2)
Depression (60)
Dermatology (61)
Diabetes (217)
Diagnostics (1387)
Digital health (13)
Diversity, equity & inclusion (6)
Drug discovery (45)
Drug pricing (33)
Drug shortages (2)
Duchenne muscular dystrophy (68)
Earnings (37620)
Editorial (13)
Employer branding (3)
Employer resources (10)
Events (23258)
Executive appointments (139)
Eye disease (1)
FDA (4301)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (5)
Frontotemporal dementia (9)
Funding (289)
Gene editing (55)
Generative AI (9)
Gene therapy (165)
GLP-1 (334)
Government (844)
Grass and pollen (2)
Guidances (311)
Healthcare (4079)
Hematology (56)
HIV (30)
Huntington's disease (17)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (34)
Immunology and inflammation (85)
Immuno-oncology (22)
Indications (84)
Infectious disease (665)
Inflammatory bowel disease (57)
Inflation Reduction Act (1)
Influenza (31)
Intellectual property (43)
Interviews (28)
IPO (5130)
IRA (8)
Job creations (587)
Job search strategy (132)
JPM (11)
Kidney cancer (12)
Kidney disease (22)
Labor market (26)
Layoffs (125)
Leadership (6)
Legal (946)
Licensing (4)
Liver cancer (23)
Longevity (5)
Lung cancer (378)
Lung diease (3)
Lymphoma (173)
Machine learning (9)
Manufacturing (221)
Marketing (5)
MASH (60)
Medical affairs (2)
Medical device (3036)
Medtech (3085)
Mergers & acquisitions (3511)
Metabolic disorders (505)
mRNA (33)
Multiple sclerosis (77)
NASH (7)
Netherlands (6)
Neurodegenerative disease (101)
Neuropsychiatric disorders (39)
Neuroscience (889)
Neurotech (1)
NextGen: Class of 2026 (1078)
Non-profit (832)
Now hiring (8)
Obesity (226)
Opinion (32)
Ovarian cancer (62)
Pain (72)
Pancreatic cancer (91)
Parkinson's disease (76)
Partnered (4)
Patents (94)
Patient recruitment (146)
Patient selection (7)
Peanut (14)
People (6147)
Peptides (1)
Pharmaceutical (2)
Pharmacy benefit managers (4)
Phase 1 (4373)
Phase 2 (7155)
Phase 3 (6959)
Pipeline (4554)
Policy (35)
Postmarket research (676)
Preclinical (1377)
Press Release (6)
Prostate cancer (123)
Psychedelics (11)
Radioligand (1)
Radiopharmaceuticals (90)
Rare diseases (303)
Real estate (747)
Recruiting (3)
Regenerative medicine (2)
Regulatory (4962)
Reports (22)
Research institute (425)
Resumes & cover letters (19)
Rett syndrome (14)
RNA editing (5)
RSV (23)
Schizophrenia (75)
Series A (41)
Series B (24)
Sickle cell disease (39)
Special edition (10)
Spinal muscular atrophy (34)
Sponsored (8)
Startups (411)
Stem cells (1)
Stomach cancer (4)
Substance use disorders (2)
Supply chain (20)
Tariffs (16)
The Weekly (16)
Vaccines (233)
Venture capital (22)
Weight loss (170)
Wet AMD (1)
Women's health (33)
Worklife (4)
Date
Today (10)
Last 7 days (142)
Last 30 days (652)
Last 365 days (7867)
2026 (5934)
2025 (7768)
2024 (8865)
2023 (9879)
2022 (10967)
2021 (11601)
2020 (11309)
2019 (9160)
2018 (6791)
2017 (6094)
2016 (5407)
2015 (6761)
2014 (5079)
2013 (3705)
2012 (4010)
2011 (4340)
2010 (3650)
Location
Africa (141)
Alabama (24)
Arizona (62)
Arkansas (3)
Asia (8584)
Australia (1198)
California (3724)
Canada (955)
China (468)
Colorado (177)
Connecticut (199)
Delaware (157)
Europe (20221)
Florida (558)
Georgia (132)
Hawaii (1)
Idaho (12)
Illinois (278)
India (24)
Indiana (224)
Iowa (1)
Japan (246)
Kansas (27)
Kentucky (12)
Louisiana (18)
Maine (35)
Maryland (425)
Massachusetts (2557)
Michigan (103)
Minnesota (209)
Mississippi (3)
Missouri (26)
Montana (4)
Nebraska (1)
Nevada (33)
New Hampshire (56)
New Jersey (1487)
New Mexico (18)
New York (1184)
North Carolina (738)
North Dakota (6)
Northern California (1946)
Ohio (138)
Oklahoma (5)
Oregon (4)
Pennsylvania (750)
Puerto Rico (6)
Rhode Island (8)
South America (190)
South Carolina (10)
Southern California (1546)
Tennessee (60)
Texas (563)
United States (14022)
Utah (122)
Virginia (64)
Washington D.C. (9)
Washington State (258)
West Virginia (2)
Wisconsin (28)
Wyoming (2)
139,328 Results for "14".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Battelle Funds 16 Central Ohio STEM Programs Serving 14,000 Youth
June 15, 2026
·
5 min read
Press Releases
Novo Nordisk A/S - share repurchase programme - September 14, 2026
September 14, 2026
·
2 min read
Layoffs
Spurred by deep cuts and M&A activity, H1 layoffs could oust 14,000+ in biopharma
Takeda’s cuts will go the deepest, affecting over 4,700 employees. Layoffs tied to M&A activity include BioNTech letting go of around 800 people at CureVac.
July 16, 2026
·
6 min read
·
Angela Gabriel
Press Releases
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - September 14, 2026
September 14, 2026
·
2 min read
Press Releases
4DMT Announces New Employment Inducement Grants - August 14, 2026
August 16, 2026
·
2 min read
Press Releases
Sol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026
September 30, 2026
·
7 min read
Press Releases
Compass Pathways to Participate in Investor Conferences the Week of September 14th
September 10, 2026
·
2 min read
Press Releases
Emmaus Life Sciences Reports Quarterly Financial Results - August 14, 2026
August 16, 2026
·
7 min read
Press Releases
Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker
September 22, 2026
·
5 min read
Press Releases
Tempo Therapeutics Closes Oversubscribed $14.5 Million Financing to Advance MAP(TM) Regenerative Technology
September 16, 2026
·
5 min read
1 of 13,933
Next
